Clene Inc - CLNN Earnings growth forecast for next year
The success of Clene Inc. (CLNN) relies on the confirmation of the neuroprotective properties of gold nanoparticles, although geopolitical tensions are hindering logistics and global testing. The projected change in earnings per share for the coming year on the GURU.Markets terminal chart demonstrates the impact of these factors, where the 31.70 parameter determines the magnitude of the metric. The situation is further complicated by an acute liquidity shortage required to pass regulatory reviews.
CLNN (Clene): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt and liquidity data:
- net income and valuation ratios data:
CLNN - Company Profit|Expected Profit Clene Inc.|CLNN - Price to Earnings Multiple|Forward P/E Multiple Clene Inc|CLNN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Clene|CLNN - Operating profit EBITDA|Earnings per share for the last twelve months Clene|CLNN - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months clene.com|CLNN - Earnings per share growth rate in current year|Earnings growth forecast for next year Clene Inc.
Comprehensive company analysis:CLNN, Clene Inc.
This indicator measures the expected percentage difference between current and future net earnings per share by aggregating expert consensus forecasts. Analyzing this GURU.Markets chart of expected EPS growth for the coming year, an investor can see the trend of market expectations regarding business profitability. For Clene Inc. (CLNN), this forecast depends critically on the success of costly R&D and passing stringent FDA controls for unique nanotechnologies.
Key competitors
Expected earnings per share growth for next year BIIB|NBIX: Expected earnings per share trend next year|Earnings growth forecast for next year RGC|Consensus forecast of earnings per share growth for next year axsome.com|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|XENE: Projected earnings per share growth rate for next year|Viking Pharma - Earnings growth forecast for next year|Supernus Corp (SUPN) - Expected earnings per share growth for next year|CPRX (Catalyst Pharmaceuticals) - Expected earnings per share growth for next year|DNLI - Consensus forecast of earnings per share growth for next year|HRMY (Harmony Biosciences Holdings, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Biohaven Ltd (BHVN)|Net earnings per share growth forecast for next year Amylyx (AMLX)|Net earnings per share growth forecast for next year TRVI (Trevi Corp)|Net earnings per share growth forecast for next year Praxis Precision Medicines PRAX|AVXL: Projected earnings per share growth rate for next year|CBLL - Net earnings per share growth forecast for next year|PRTA (Prothena Corporation plc) - Projected earnings per share growth rate for next year|alector.com (ALEC) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year neurogene.com NGNE|Expected earnings per share growth for next year ACIU (AC Immune SA)|Earnings growth forecast for next year Voyager Therapeutics Inc (VYGR)|Net earnings per share growth forecast for next year Neumora Therapeutics Inc NMRA|Expected earnings per share trend next year SCLX|TVGN - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Alpha Cognition|CGTX: Earnings growth forecast for next year|Expected earnings per share growth for next year Inhibikase Therapeutics Inc|Net earnings per share growth forecast for next year Cassava|Net earnings per share growth forecast for next year ASRT|Earnings growth forecast for next year COYA|VTGN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|ABOS: Projected earnings per share growth rate for next year|CervoMed Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Alterity Therapeutics|PEPG (pepgen.com) - Expected earnings per share growth for next year|Jupiter Neurosciences, Inc. - Expected earnings per share trend next year|RLMD (Relmada Therapeutics, Inc.) - Earnings growth forecast for next year|Annovis Bio Inc (ANVS) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Grace Therapeutics, Inc. (GRCE)|Firefly Neuro - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KLTO (Klotho Neurosciences)|NRSN - Expected earnings per share growth for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia Inc MTVA|NRXS: Earnings growth forecast for next year|Expected earnings per share growth for next year Helius Medical Technologies|Net earnings per share growth forecast for next year Passage Bio Inc.|Net earnings per share growth forecast for next year NEUP|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|Athira Pharma Inc - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Addex Therapeutics, Ltd. ADXN|ALZN: Projected earnings per share growth rate for next year|CYCN - Net earnings per share growth forecast for next year|PTIX (Protagenic Therapeutics) - Projected earnings per share growth rate for next year|KTTA: Earnings growth forecast for next year|Expected net earnings per share growth next year Cortigent (CRGT)|Expected earnings per share growth for next year ATXI|Earnings growth forecast for next year BrainStorm Cell Therapeutics Inc.|Net earnings per share growth forecast for next year Cara Therapeutics, Inc. (CARA)|CHRO (chromocell.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. (ITCI) - Expected net earnings per share growth next year|Longboard Pharma - Earnings growth forecast for next year|Marinus Pharma (MRNS) - Expected earnings per share growth for next year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|NRBO (neurobopharma.com) - Net earnings per share growth forecast for next year|SAGE (Sage Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year Synaptogenix Inc. SNPX|Net earnings per share growth forecast for next year Trevena, Inc (TRVN)|vigilneuro.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year WENA (Anew Medical)|cerevel.com (CERE) - Expected net earnings per share growth next year
